Wird geladen...
A6V polymorphism of the human μ-opioid receptor decreases signalling of morphine and endogenous opioids in vitro
BACKGROUND AND PURPOSE: Polymorphisms of the μ opioid receptor (MOPr) may contribute to the variation in responses to opioid drugs in clinical and unregulated situations. The A6V variant of MOPr (MOPr-A6V) is present in up to 20% of individuals in some populations, and may be associated with heighte...
Gespeichert in:
| Veröffentlicht in: | Br J Pharmacol |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BlackWell Publishing Ltd
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4403092/ https://ncbi.nlm.nih.gov/pubmed/25521224 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13047 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|